NCT01448395View on ClinicalTrials.gov

Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]NXL104

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Healthy

Interventions

DRUG

[14C]NXL104

500mg/100mL intravenous solution

Trial Locations (1)

Unknown

Study site, Ruddington

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT01448395 - Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]NXL104 | Biotech Hunter | Biotech Hunter